New therapies for hepatitis C
β
Apurva A. Modi; Jay H. Hoofnagle
π
Article
π
2007
π
John Wiley and Sons
π
English
β 57 KB
See Articles on Pages 631 and 640. N o challenge in clinical hepatology is as great today as the management of patients with chronic hepatitis C who have failed to respond to an adequate course of antiviral therapy. At present, the optimal regimen is a combination of peginterferon and ribavirin. 1 W